UMIN ID: C000000159
Registered date:01/04/2006
Mizolibin for systemic lupus erythematosus in children(JSRDC10)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | systematic lupus erythematosus |
| Date of first enrollment | 2006/03/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Methylprednisolone+mizoribine+prednisolone |
Outcome(s)
| Primary Outcome | flare proportion |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 2years-old |
|---|---|
| Age maximum | 18years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1.Chronic rheumatoid arthritis, diffuse scleroderma or dermatomyositis. 2.History of immunosuppressive drugs administration. 3.Medical history of allergy or hypersensitivity reactions to mizoribine. 4.Poorly controlled hypertension. 5.Active infectious disease. 6.Severe liver disfunction. 7.Pregnancy. 8.Judged inappropriate for this study by the physicians. |
Related Information
| Primary Sponsor | Japanese Study Group of Renal Disease in Children(JSRDC) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | The Kidney Foundation,Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | 2-8-29 Musashinodai, Fuchu-shi, TOKYO, JAPAN Japan |
| Telephone | |
| Affiliation | Japanese Study Group of Renal Disease in Children(JSRDC) Tokyo Metropolitan Children's Medical Center |
| scientific contact | |
| Name | Masataka Honda |
| Address | 2-8-29 Musashinodai, Fuchu-shi, TOKYO, JAPAN Japan |
| Telephone | |
| Affiliation | Tokyo Metropolitan Children's Medical Center Department of Pediatric nephrology |